105 related articles for article (PubMed ID: 1686602)
61. [Scedosporium prolificans: disseminated infection in immunocompromised patient].
Fernández-Mosteirín N; Salvador-Osuna C; Mayayo P; García-Zueco JC
Med Clin (Barc); 2003 Mar; 120(8):317-8. PubMed ID: 12636905
[No Abstract] [Full Text] [Related]
62. Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis.
Okabe S; Tauchi T; Nakajima A; Sashida G; Gotoh A; Broxmeyer HE; Ohyashiki JH; Ohyashiki K
Stem Cells Dev; 2007 Jun; 16(3):503-14. PubMed ID: 17610380
[TBL] [Abstract][Full Text] [Related]
63. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K
Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844
[TBL] [Abstract][Full Text] [Related]
64. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot G; Weber G
Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
[TBL] [Abstract][Full Text] [Related]
65. Idarubicin in blastic crisis of chronic myelogenous leukemia.
Lambertenghi-Deliliers G; Annaloro C; Cortellaro M; Pozzoli E; Oriani A; Polli EE
Haematologica; 1991; 76(5):406-8. PubMed ID: 1806446
[TBL] [Abstract][Full Text] [Related]
66. Disappearance of Ph1 chromosome with intensive chemotherapy and detection of minimal residual disease by polymerase chain reaction in a patient with blast crisis of chronic myelogenous leukemia.
Honda H; Miyagawa K; Endo M; Takaku F; Yazaki Y; Hirai H
Int J Hematol; 1993 Jun; 57(3):221-7. PubMed ID: 8364186
[TBL] [Abstract][Full Text] [Related]
67. High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.
Rea D; Legros L; Raffoux E; Thomas X; Turlure P; Maury S; Dupriez B; Pigneux A; Choufi B; Reman O; Stéphane D; Royer B; Vigier M; Ojeda-Uribe M; Recher C; Dombret H; Huguet F; Rousselot P; ;
Leukemia; 2006 Mar; 20(3):400-3. PubMed ID: 16437142
[TBL] [Abstract][Full Text] [Related]
68. Bcr-abl positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecan.
Buxhofer-Ausch V; Hinterberger-Fischer M; Hinterberger W
Eur J Haematol; 2006 May; 76(5):447-8. PubMed ID: 16494624
[No Abstract] [Full Text] [Related]
69. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
[TBL] [Abstract][Full Text] [Related]
70. [Ponatinib: new option for the treatment of resistant chronic myeloid leukemia].
Camañas-Troyano C; Calderón-Acedos C; Moriel-Sánchez Mdel C; Segura-Bedmar M
Farm Hosp; 2013; 37(5):428-9. PubMed ID: 24128110
[No Abstract] [Full Text] [Related]
71. Mithramycin therapy for resistant hypercalcaemia in transformed chronic granulocytic leukaemia.
Collin R; Griffiths H; Polacarz SV; Lawrence AC; Watmore A
Clin Lab Haematol; 1989; 11(2):156-9. PubMed ID: 2527665
[No Abstract] [Full Text] [Related]
72. P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.
Beksaç M; Akan H; Koç H; Ilhan O; Ertürk S; Güneyli A; Ikizünal Y; Sardaş OS
Med Oncol Tumor Pharmacother; 1992; 9(2):101-5. PubMed ID: 1364132
[TBL] [Abstract][Full Text] [Related]
73. Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia.
Archimbaud E; Troncy J; Sebban C; Guyotat D; Devaux Y; French M; Moriceau M; Viala JJ; Fiere D
Cancer Chemother Pharmacol; 1989; 25(3):223-5. PubMed ID: 2532073
[TBL] [Abstract][Full Text] [Related]
74. Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
; Simonsson B
Ann Oncol; 2007 Apr; 18 Suppl 2():ii51-2. PubMed ID: 17491046
[No Abstract] [Full Text] [Related]
75. Complex neuromuscular disorder in a patient with chronic myeloid leukaemia.
Bergin PS; Gale AN
Postgrad Med J; 1993 Apr; 69(810):312-4. PubMed ID: 8321800
[TBL] [Abstract][Full Text] [Related]
76. Biological determinants of long-term survival in chronic myelogenous leukemia patients treated with conventional chemotherapy.
Foa P; Iurlo A; Orazi A; Saglio G; Ribera S; Bertoni F; Caldiera S; Fornier M; Maiolo AT
Acta Haematol; 1997; 97(3):187-8. PubMed ID: 9066716
[No Abstract] [Full Text] [Related]
77. A new purpose for an old drug: inhibiting autophagy with clarithromycin.
Altman JK; Platanias LC
Leuk Lymphoma; 2012 Jul; 53(7):1255-6. PubMed ID: 22288786
[No Abstract] [Full Text] [Related]
78. [Changes in the level of extracellular DNA and free polyamines in the blood of patients with chronic myeloleukemia].
Pan'kov VN; Voronchikhina LD; Dem'ianova VT; Beznosikova TP; Kolupaeva NV
Gematol Transfuziol; 1988 Aug; 33(8):45-8. PubMed ID: 3192057
[No Abstract] [Full Text] [Related]
79. Reversal of P-glycoprotein-associated multidrug resistance: the challenge continues.
Lehnert M
Eur J Cancer; 1993; 29A(4):636-8. PubMed ID: 8094624
[No Abstract] [Full Text] [Related]
80. Hydroxyurea and 6-mercaptopurine in the treatment of chronic granulocytic leukemia.
Lazzarino M; Morra E; Brusamolino E; Inverardi D; Castelli G; Merante S; Bernasconi C
Am J Clin Oncol; 1986 Feb; 9(1):45-9. PubMed ID: 3513537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
